1. A separator for a fuel cell, comprising: a base formed of a steel which contains 10.5 mass % or more of Cr; a metal film formed on a surface of the base; and an intermediate layer formed between the base and the metal film, the intermediate layer containing oxygen, wherein the metal film is composed of Au or Pt, and the intermediate layer contains Fe and Cr which are contained in the steel and Au or Pt composing the metal film.
2. The separator for a fuel cell of claim 1, wherein a depth-direction profile showing an oxygen content in the intermediate layer has a local maximum.
3. The separator for a fuel cell of claim 1, wherein a depth-direction profile showing an Au or Pt content in the intermediate layer decreases from the metal film toward the base and depth-direction profiles showing Fe and Cr contents in the intermediate layer increase from the metal film toward the base.
4. The separator for a fuel cell of claim 1, wherein the steel further contains 5 to 16 mass % of Ni, and the intermediate layer contains: Fe, Cr, and Ni which are contained in the steel; and Au or Pt composing the metal film.
5. The separator for a fuel cell of claim 4, wherein a depth-direction profile showing an Au or Pt content in the intermediate layer decreases from the metal film toward the base, and depth-direction profiles showing Fe, Cr, and Ni contents in the intermediate layer increases from the metal film toward the base.
6. The separator for a fuel cell of claim 1, wherein the intermediate layer has a thickness of 0.050 \u03bcm or more when a thickness of the metal film is equal to or greater than 0.03 \u03bcm and less than 0.10 \u03bcm; the intermediate layer has a thickness of 0.030 \u03bcm or more when a thickness of the metal film is equal to or greater than 0.10 \u03bcm and less than 0.30 \u03bcm; and the intermediate layer has a thickness of 0.0020 \u03bcm or more when a thickness of the metal film is equal to or greater than 0.30 \u03bcm.
7. The separator for a fuel cell of claim 1, wherein the steel is a stainless steel.
8. The separator for a fuel cell of claim 4, wherein the steel is an austenite-type stainless steel or an austenite-ferrite-type stainless steel.
9. The separator for a fuel cell of claim 1, wherein the fuel cell is a polymer electrolyte fuel cell.
10. A fuel cell comprising any one of the separators for a fuel cell of claim 1.
11. A method of producing a separator for a fuel cell, comprising:
a step of providing a base formed of a steel which contains 10.5 mass % or more of Cr, with an oxide layer being formed on at least a portion of a surface thereof the oxide layer containing oxides of Fe and Cr;
a step of, through an ion bombard process, removing a portion of the oxide layer so as to leave a portion of the oxide layer;
a step of forming an intermediate layer containing an element contained in the oxide layer and an element composing the metal film; and
a step of, by a vapor deposition technique, depositing a metal film on the intermediate layer.
12. The method of producing a separator for a fuel cell of claim 11, wherein, through the ion bombard process, a portion is removed from the surface of the oxide layer to a depth of 0.0010 \u03bcm or more.
13. The method of producing a separator for a fuel cell of claim 11, wherein the step of forming the intermediate layer alternately performs a step of depositing the metal film and a step of performing an ion bombardment process.
14. The method of producing a separator for a fuel cell of claim 11, wherein the vapor deposition technique is a sputtering technique or an ion plating technique.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
1. A nucleic acid coding for the human cell volume-regulated kinase h-sgk having the amino acid sequence shown in FIG. 2.
2. A nucleic acid having the nucleotide sequence shown in FIG. 1.
3. A nucleic acid which hybridizes with the nucleic acid as claimed in claim 1 or 2 under stringent conditions and which codes for a functionally active cell volume-regulated kinase whose transcription can be induced neither by fetal calf serum (FCS) nor by a glucocorticoid.
4. A nucleic acid which hybridizes with the nucleic acid as claimed in claim 1 or 2 under stringent conditions and which codes for a functionally active cell volume-regulated kinase which is not identical to rat sgk.
5. A nucleic acid fragment comprising approximately the region of nucleotide position 980 to 1480 of the nucleic acid as claimed in claim 1 or 2.
6. A nucleic acid fragment coding for an immunologically active fragment of the human cell volume-regulated kinase h-sgk.
7. A nucleic acid fragment as claimed in claim 6, coding for a fragment having at least one of the following amino acid sequences:
DPEFTEEPVPNSIGKSPDS (1)
EAFLGFSYAPPTDSFL (2)
8. Human cell volume-regulated kinase h-sgk or fragments thereof, obtainable by recombinant expression of the nucleic acid as claimed in one or more of claims 1 to 7.
9. Human cell volume-regulated kinase h-sgk having the amino acid sequence shown in FIG. 2.
10. An immunogenic peptide having at least one of the following amino acid sequences:
DPEFTEEPVPNSIGKSPDS (1)
EAFLGFSYAPPTDSFL (2)
11. A receptor which binds specifically to the human cell volume-regulated kinase h-sgk as claimed in claim 8 or 9.
12. A receptor as claimed in claim 11, which comprises monoclonal or polyclonal antibodies.
13. The use of the nucleic acid as claimed in one or more of claims 1 to 7 or of a fragment of this nucleic acid for detecting a nucleic acid coding for the human cell volume-regulated kinase h-sgk.
14. The use of the nucleic acid as claimed in one or more of claims 1 to 7 or of a fragment of this nucleic acid for detecting a nucleic acid coding for the human cell volume-regulated kinase h-sgk in a Northern blot or by hybridization.
15. The use of the human cell volume-regulated kinase h-sgk as claimed in either of claims 8 or 9 or of a peptide as claimed in claim 10 for detecting receptors which bind to the h-sgk.
16. The use of receptors as claimed in any of claims 11 or 12 for the qualitative or quantitative detection of the human cell volume-regulated kinase h-sgk.
17. The use as claimed in claim 16, which involves an immunochemical method.
18. A process for preparing polyclonal or monoclonal antibodies, which comprises using at least one of the peptides as claimed in claim 10 for immunizing experimental animals.
19. The use of the nucleic acid as claimed in one or more of claims 1 to 4 or of a fragment as claimed in one or more of claims 5 to 7 or of the human cell volume-regulated kinase h-sgk as claimed in claim 8 or 9 or of the peptides as claimed in claim 10 for detecting changes in cell volume.
20. A pharmaceutical comprising the nucleic acid as claimed in one or more of claims 1 to 4 or a fragment as claimed in one or more of claims 5 to 7 or the human cell volume-regulated kinase h-sgk as claimed in one or more of claims 8 and 9 or a peptide as claimed in claim 10 or receptors as claimed in one or more of claims 11 and 12.